Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Cipla Limited
  6. Summary
    CIPLA   INE059A01026

CIPLA LIMITED

(CIPLA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
895.65(c) 882.35(c) 867.45(c) 892.1(c) 905.65(c) Last
1 413 292 1 614 683 1 669 132 4 992 078 2 322 693 Volume
-0.72% -1.48% -1.69% +2.84% +1.52% Change
More quotes
Estimated financial data (e)
Sales 2022 216 B 2 885 M 2 885 M
Net income 2022 28 200 M 377 M 377 M
Net cash position 2022 23 613 M 316 M 316 M
P/E ratio 2022 26,0x
Yield 2022 0,57%
Sales 2023 234 B 3 123 M 3 123 M
Net income 2023 33 401 M 446 M 446 M
Net cash position 2023 48 414 M 647 M 647 M
P/E ratio 2023 21,9x
Yield 2023 0,63%
Capitalization 731 B 9 774 M 9 766 M
EV / Sales 2022 3,28x
EV / Sales 2023 2,92x
Nbr of Employees 25 672
Free-Float 61,9%
More Financials
Company
Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled... 
Sector
Pharmaceuticals
Calendar
01/25Earnings Release
More about the company
Ratings of Cipla Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CIPLA LIMITED
01:56aCipla Books Slightly Lower Consolidated Profit in Fiscal Q3; EPS Beats Estimates
MT
01/25Cipla to Transfer India-Based US Undertaking and Consumer Business to Subsidiaries
MT
01/25CIPLA : Q3 FY22 Press release
PU
01/25CIPLA : Q3 FY22 Investor presentation
PU
01/25CIPLA : Extract of Unaudited Consolidated Financial Results – 31st December 2021
PU
01/25CIPLA : Unaudited financial results (standalone and consolidated) for the quarter and nine..
PU
01/25Maruti, Axis Bank help Indian shares break 5-day losing streak
RE
01/25Indian shares fall amid Fed, Ukraine anxiety; Axis Bank surges
RE
01/24Indian Benchmarks Close Lower for Fifth Straight Day; JSW Steel Plunges 7%
MT
01/15CIPLA : Compliance Report on Corporate Governance
PU
01/13CIPLA : wins the prestigious Frost & Sullivan and TERI's Sustainability 4.0 Award 2021 as ..
PU
01/12Cipla Arm to Remain Avenue Therapeutics Shareholder Despite Termination of Acquisition
MT
01/12CIPLA : Acquisition
PU
01/12CIPLA : JP Morgan Healthcare Conference
PU
01/03Indian Indices End in the Green on First Trading Day of 2022; Coal India Jumps 6%
MT
More news
News in other languages on CIPLA LIMITED
01:56aCipla enregistre un bénéfice consolidé légèrement inférieur au troisième trimestre fisc..
01/25Cipla transfère son entreprise américaine basée en Inde et ses activités grand public à..
01/25Les actions indiennes chutent pour la sixième journée sur fond d'inquiétudes concernant..
01/24Les indices indiens clôturent en baisse pour la cinquième journée consécutive ; JSW Ste..
01/12Le bras de Cipla restera actionnaire d'Avenue Therapeutics malgré la fin de l'acquisiti..
More news
Analyst Recommendations on CIPLA LIMITED
More recommendations
Chart CIPLA LIMITED
Duration : Period :
Cipla Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIPLA LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 35
Last Close Price 905,65 INR
Average target price 1 056,83 INR
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Umang Vohra Global Chief Executive Officer, MD & Director
Raju Mistry President & Global Chief People Officer
Kedar Upadhye Global Chief Financial Officer
Yusuf Khwaja Hamied Non-Executive Chairman
Jaideep A. Gogtay Global Chief Medical Officer